Percutaneous closure of an atrial septal defect in an infant with Shone's syndrome

Christopher J Petit1, Henri Justino, Charles D Fraser

  • 1Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Texas Children's Hospital, Houston, Texas 77030, USA. petit@bcm.edu

Insights

Closure of an atrial septal defect (ASD) in infants is rare but can be life-saving. This case study shows successful percutaneous ASD closure improved an infant with Shone's syndrome, enabling better left heart growth.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Atrial septal defects (ASDs) are rarely closed in infants.
  • Congenital mitral stenosis with ASD can cause infant congestive heart failure.
  • Shone's syndrome involves multiple left-sided heart obstructions.

Observation:

  • An infant with Shone's syndrome, left ventricular hypoplasia, and a large ASD developed pulmonary overcirculation post-coarctation repair.
  • The infant underwent cardiac catheterization and hemodynamic assessment.
  • Successful percutaneous closure of the ASD was performed.

Findings:

  • The infant showed dramatic clinical improvement after ASD closure.
  • Follow-up echocardiograms revealed growth in mitral valve annulus diameter and left ventricular dimensions.
  • Percutaneous ASD closure led to immediate clinical improvement and enhanced left heart development.

Implications:

  • Percutaneous ASD closure is a viable option for select infants with complex congenital heart disease.
  • Early intervention can improve hemodynamics and promote growth of underdeveloped left heart structures.
  • This approach may prevent long-term complications associated with untreated ASDs in this population.

Related Concept Videos